Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
403
mi
from 43215
Canton, GA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
403
mi
from 43215
Canton, GA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
320
mi
from 43215
Rockville, MD
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
320
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
637
mi
from 43215
Belmont, MA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
637
mi
from 43215
Belmont, MA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
356
mi
from 43215
Traverse City, MI
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
356
mi
from 43215
Traverse City, MI
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
405
mi
from 43215
Creve Coeur, MO
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
405
mi
from 43215
Creve Coeur, MO
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1333
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
513
mi
from 43215
Albany, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
513
mi
from 43215
Albany, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
301
mi
from 43215
Amherst, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
301
mi
from 43215
Amherst, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
517
mi
from 43215
Latham, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
517
mi
from 43215
Latham, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
472
mi
from 43215
Staten Island, NY
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
472
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
371
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
130
mi
from 43215
Beachwood, OH
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
130
mi
from 43215
Beachwood, OH
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
121
mi
from 43215
Toledo, OH
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
121
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2057
mi
from 43215
Eugene, OR
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2057
mi
from 43215
Eugene, OR
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2026
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
621
mi
from 43215
East Providence, RI
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
621
mi
from 43215
East Providence, RI
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
351
mi
from 43215
Greer, SC
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
351
mi
from 43215
Greer, SC
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
747
mi
from 43215
Sioux Falls, SD
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
747
mi
from 43215
Sioux Falls, SD
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1513
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
547
mi
from 43215
Bennington, VT
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
547
mi
from 43215
Bennington, VT
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
590
mi
from 43215
Burlington, VT
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
251
mi
from 43215
Roanoke, VA
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
251
mi
from 43215
Roanoke, VA
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
5386
mi
from 43215
Buenos Aires,
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
5386
mi
from 43215
Buenos Aires,
Click here to add this to my saved trials
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1639
mi
from 43215
Tucson, AZ
Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease
Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172
BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Research Institute
1669
mi
from 43215
Sun City, AZ
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Research Institute
1669
mi
from 43215
Sun City, AZ
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
1958
mi
from 43215
Irvine, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
1958
mi
from 43215
Irvine, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
1953
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California, Davis
2087
mi
from 43215
Martinez, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California, Davis
2087
mi
from 43215
Martinez, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine (Brain Imaging Center)
1959
mi
from 43215
Orange, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine (Brain Imaging Center)
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Stanford University / PAIRE
2101
mi
from 43215
Palo Alto, CA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Stanford University / PAIRE
2101
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Wien Center for Clinical Research
991
mi
from 43215
Miami Beach, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Wien Center for Clinical Research
991
mi
from 43215
Miami Beach, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Premiere Research Institute
928
mi
from 43215
West Palm Beach, FL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Premiere Research Institute
928
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated:  12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Alzheimer's Disease Neuroimaging Initiative 2
Alzheimer's Disease Neuroimaging Initiative 2
Status: Enrolling
Updated: 12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials